Testing a heart pump for severe right heart failure
Part of Heart & circulation clinical trials.
This trial is evaluating a new temporary heart pump called CorVad for people who develop severe right heart failure shortly after heart surgery, a heart attack, or a heart transplant. The pump is designed to help the right side of the heart pump blood when medications are not enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have severe right heart failure within 48 hours of heart surgery, a heart attack, or a heart transplant that does not get better with strong medications.
- Your heart function must meet specific measurements, such as low cardiac index or signs of right heart strain on an ultrasound.
- You cannot be in critical condition requiring immediate emergency life support (INTERMACS 1).
- You cannot have severe liver or kidney problems, active infections, blood clots in the heart, or uncontrolled bleeding risk.
- You cannot be pregnant or breastfeeding, or be in another conflicting clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.
This study is testing a heart pump device for people with very advanced heart failure. It's for patients who are very sick and haven't improved with standard treatments. The study will see if this pump is safe and effective.
This trial tests a temporary heart pump to support patients with weak hearts (ejection fraction 35% or less) who need a high-risk stent procedure instead of bypass surgery. The pump may help keep blood flowing during the procedure.
This study tests a new type of heart pump (the DuoCor 2) designed to support both the left and right sides of the heart. The pump is implanted during surgery and may help people with very advanced heart failure feel better and live longer.
This trial tests a new heart pump device (CorVad) to support the heart in people who are in cardiogenic shock after a heart attack. It may help stabilize blood pressure and improve blood flow, potentially giving the heart time to recover.
This trial tests a new left-ventricular assist device (LVAD) called BrioVAD for people with advanced heart failure who are not getting enough benefit from medicines. If you qualify, the device is implanted to help your heart pump blood.
Hear when a new Right Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.